Abstract
The drug preparation `Nucliderm-gel` (BG patent document No. 68170/1984) is a gel formation containing native polynucleotide complex from thymus gland as an active component. The preparation is licensed in 1989 for production and usage by the Bulgarian Medical Drugs Commission. It has been applied in 43 patients (a total of 122 input fields) with acute or delayed radiodermatitis developed as a side effect after radiotherapy. The clinical surveillance of the skin reactions (erythema, edema, erosion, ulcer, skin atrophy and rhagades) show that this new preparation is a good stimulator of the granulation and epithelization processes. The drug has also a pronounced antiphlogistic and antinecrotic ability. (A.B.).
Citation Formats
Stefanova, D, Georgieva, R, and Pandova, V.
Local radiation injuries of skin - prophylaxis and therapy.
Bulgaria: N. p.,
1992.
Web.
Stefanova, D, Georgieva, R, & Pandova, V.
Local radiation injuries of skin - prophylaxis and therapy.
Bulgaria.
Stefanova, D, Georgieva, R, and Pandova, V.
1992.
"Local radiation injuries of skin - prophylaxis and therapy."
Bulgaria.
@misc{etde_10136387,
title = {Local radiation injuries of skin - prophylaxis and therapy}
author = {Stefanova, D, Georgieva, R, and Pandova, V}
abstractNote = {The drug preparation `Nucliderm-gel` (BG patent document No. 68170/1984) is a gel formation containing native polynucleotide complex from thymus gland as an active component. The preparation is licensed in 1989 for production and usage by the Bulgarian Medical Drugs Commission. It has been applied in 43 patients (a total of 122 input fields) with acute or delayed radiodermatitis developed as a side effect after radiotherapy. The clinical surveillance of the skin reactions (erythema, edema, erosion, ulcer, skin atrophy and rhagades) show that this new preparation is a good stimulator of the granulation and epithelization processes. The drug has also a pronounced antiphlogistic and antinecrotic ability. (A.B.).}
place = {Bulgaria}
year = {1992}
month = {Dec}
}
title = {Local radiation injuries of skin - prophylaxis and therapy}
author = {Stefanova, D, Georgieva, R, and Pandova, V}
abstractNote = {The drug preparation `Nucliderm-gel` (BG patent document No. 68170/1984) is a gel formation containing native polynucleotide complex from thymus gland as an active component. The preparation is licensed in 1989 for production and usage by the Bulgarian Medical Drugs Commission. It has been applied in 43 patients (a total of 122 input fields) with acute or delayed radiodermatitis developed as a side effect after radiotherapy. The clinical surveillance of the skin reactions (erythema, edema, erosion, ulcer, skin atrophy and rhagades) show that this new preparation is a good stimulator of the granulation and epithelization processes. The drug has also a pronounced antiphlogistic and antinecrotic ability. (A.B.).}
place = {Bulgaria}
year = {1992}
month = {Dec}
}